439
Views
28
CrossRef citations to date
0
Altmetric
Drospirenone Only Pill and Hemostasis

Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 + 4 cycle with desogestrel 75 μg per day

, &
Pages 749-751 | Received 20 Jan 2016, Accepted 01 Mar 2016, Published online: 30 Mar 2016
 

Abstract

Introduction: A novel estrogen free contraceptive pill, with drospirenone 4 mg in a dosing regimen of 24 + 4, has been developed with a pearl-index of 0.51 (95% CI 0.1054; 1.4922). The aim of the following study was to determine if 4 mg DRSP has an impact on coagulation factors and thrombotic risks in comparison with desogestrel 75 μg.

Patients and methods: Thirty-nine patients received 4 mg DRSP 24 + 4 d and 29 desogestrel 75 μg per day continuously during nine complete cycles. Following hemostatic parameters were evaluated: Apc resistance, Antithrombin III, Protein C reactivity, Factor VII, Factor VIII, and d-Dimer.

Results: Factor VII decreased from 1.123 to 1.066 in the DRSP group and from 1.241 to 1.034 in the desogestrel group (p = 0.0088). The difference in change of mean Protein C activity from baseline to endpoint was −0.0332 in the DRSP versus −0.157 in the desogestrel group (p = 0.0249). d-Dimer values dropped in the DRSP group from baseline values of 264.9–215.0 ng/mL, whereas in the desogestrel group there was a rise from 201.4 ng/mL to 281.5 ng/mL.

Discussion: DRSP 4 mg was not associated with any meaningful changes on hemostatic parameters, indicating a lack of effect on hemostasis

Chinese abstract

介绍:一种新的无雌激素避孕药, 在24 + 4的给药方案中使用4mg屈螺酮 (DRSP) , 已经开发出其比尔指数为0.51 (95%CI 0.1054;1.4922), 以下研究的目的是确定与75mg去氧孕烯相比, 4mg DRSP是否对凝血因子和血栓形成风险具有影响。

患者和方法:在9个完整周期中, 39名患者在24 + 4周期中连续接受4mg DRSP和另29名患者每日接受75mg去氧孕烯。评价以下止血参数:Apc抗性, 抗凝血酶III, C反应蛋白, 因子VII, 因子VIII和D-二聚体。

结果:在DRSP组中因子VII从1.123降至1.066, 在去氧孕烯组中因子VII从1.241降至1.034 (p = 0.0088) 。 在DRSP组中平均C反应蛋白从基线到终点的变化差异为0.0332, 而在去氧孕烯组中为0.157 (p = 0.0249) 。DRSP组中的D二聚体值从264.9-215.0ng/mL的基线值下降, 而在去氧孕烯组中, 从201.4ng/mL上升至281.5ng/mL。

讨论:4mg DRSP对止血参数没有任何有意义的改变, 表明其止血效果不明显。

Declaration of interest

P.A. Regidor is an employee of Exeltis, Germany; E. Colli is an employee of Exeltis, Spain.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.